Skip to main content

Advertisement

Log in

Investigation of therapeutic potential of cerium oxide nanoparticles in Alzheimer’s disease using transgenic Drosophila

  • Original Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

In the current study, the therapeutic potential of cerium oxide nanoparticles (nCeO2) was investigated in a human tau (htau) model of Alzheimer’s disease (AD), using Drosophila melanogaster as an in vivo model. nCeO2 synthesised via the hydroxide-mediated approach were characterised using Fourier transform infrared (FTIR), transmission electron microscopy (TEM), X-ray diffraction (XRD) analyses and Raman spectroscopy. Characterisation studies confirmed the formation of pure cubic-structured nCeO2 and showed that the particles were spherically shaped, with an average size between 20 and 25 nm. The synthesised nCeO2 were then administered as part of the diet to transgenic Drosophila for one month, at 0.1 and 1 mM concentrations, and its effect on the biochemical levels of superoxide dismutase (SOD), acetylcholinesterase (AChE), and the climbing activity of flies were studied in a pan-neuronal model (elav; htau) of AD. Using an eye-specific model of htau expression (GMR; htau), the effect of nCeO2 on htau and autophagy-related (ATG) gene expression was also studied. Dietary administration of nCeO2 at a concentration of 1 mM restored the activity of SOD similar to that of control, but both concentrations of nCeO2 failed to modulate the level of AChE, and did not elicit any significant improvements in the climbing activity of elav; htau flies. Moreover, nCeO2 at a concentration of 1 mM significantly affected the climbing activity of elav; htau flies. nCeO2 also elicited a significant decrease in htau gene expression at both concentrations and increased the mRNA expression of key autophagy genes ATG1 and ATG18. The results therefore indicate that nCeO2 aids in replenishing the levels of SOD and tau clearance via the activation of autophagy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

Download references

Acknowledgements

Dr Sahabudeen acknowledges the Department of Science and Technology (DST) −Science and Engineering Research Board (FILE NO. ECR/2016/000490) for providing financial assistance. The authors acknowledge HRTEM, XRD and Raman facilities at SRM Institute of Science and Technology set up with support from MNRE (Project No. 31/03/2014-15/PVSE-R&D), Government of India. The authors acknowledge the SRM-DBT Platform for Advanced Life Sciences for providing the facility for performing Real-Time PCR experiments. The authors also thank Mr. V.P. Narayanan Nampoothiri for technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sahabudeen Sheik Mohideen.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest in the publication.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sundararajan, V., Venkatasubbu, G.D. & Sheik Mohideen, S. Investigation of therapeutic potential of cerium oxide nanoparticles in Alzheimer’s disease using transgenic Drosophila. 3 Biotech 11, 159 (2021). https://doi.org/10.1007/s13205-021-02706-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-021-02706-x

Keywords

Navigation